QA: Artelo Biosciences INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001621221_2021_Artelo_Biosciences_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001621221, Artelo Biosciences INC

  xvar xval
0 AssetsCurrent 2,337,199
1 IntangibleAssetsNetIncludingGoodwill 2,039,417
2 PropertyPlantAndEquipmentNet 246
3 remainder_Assets 0
4 LiabilitiesCurrent 502,177
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,968,387
9 ResearchAndDevelopmentExpense 1,777,289
10 remainder_Expenses 870,731
11 remainder_Revenues 0
12 remainder_NetIncome 947,150
13 remainder_ComprehensiveNetIncome 427,903
  yvar yval
0 Assets 4,376,862
1 Liabilities 502,177
2 Expenses 8,616,407
3 Revenues 0
4 StockholdersEquity 3,874,685
5 NetIncome -7,669,257
6 ComprehensiveNetIncome -7,455,306
7 BaseVar 7,435,250
8 EconomicCapitalRatiobeforeLimitedLiability 0.406
9 EconomicCapitalRatio 1.80

Edgar->Model Mapping

Feature Distribution

Change over Time